Free Submission Public Relations & NewsPR-inside.com
Home
Deutsch English

Health

Recent Study: Amsterdam Molecular Therapeutics (AMT) Holding N.V. (AMT) - Financial and Strategic SWOT Analysis Review


Print article Print article
2012-09-13 11:19:31 - Recently published research from GlobalData, "Amsterdam Molecular Therapeutics (AMT) Holding N.V. (AMT) - Financial and Strategic SWOT Analysis Review", is now available at Fast Market Research

Amsterdam Molecular Therapeutics (AMT) Holding N.V. (AMT), formerly Amsterdam Molecular Therapeutics (AMT) Holding B.V., is a bio-pharmaceutical company with focus on developing gene-based therapies for orphan diseases. The company develops gene therapies to treat metabolic disorders, liver diseases, blood diseases, and disorders of the central and peripheral nervous systems. Its product pipeline comprises Glybera, hemophilia B gene therapy, AMT-080, AMT-021, AMT-090 and the Institut Pasteur program. It also developed an adeno-associated viral (AAV) production platform by using AAV vectors as the delivery vehicle of choice for therapeutic genes. The company along with its subsidiaries, namely, Amsterdam Molecular Therapeutics (AMT) IP B.V. and Amsterdam Molecular Therapeutics (AMT) B.V. operates in the Netherlands. AMT is headquartered in Amsterdam, the Netherlands.


Full Report Details

at
- www.fastmr.com/prod/461867_amsterdam_molecular_therapeutics_amt_ ..


The company seeks to restructure its business. To achieve this objective, AMT entered an agreement to dispose its entire business and operations to uniQure B.V.

Amsterdam Molecular Therapeutics (AMT) Holding N.V. Key Recent Developments

Apr 26, 2012: Amsterdam Molecular Therapeutics Reports 2011 Results
Nov 16, 2011: AMT Receives Orphan Designation In EU For Hemophilia B Gene Therapy
Oct 25, 2011: Amsterdam Molecular Therapeutics Provides Operations Update And Strategic Review Of Pipeline Products
Aug 25, 2011: AMT Reports H1 2011 Results
Mar 07, 2011: AMT Receives EUR145,000 Grant For Duchenne Muscular Dystrophy Gene Therapy

This comprehensive SWOT profile of Amsterdam Molecular Therapeutics (AMT) Holding N.V. provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

* Business description - A detailed description of the company's operations and business divisions.
* Corporate strategy - Analyst's summarization of the company's business strategy.
* SWOT Analysis - A detailed analysis of the company's strengths, weakness, opportunities and threats.
* Company history - Progression of key events associated with the company.
* Major products and services - A list of major products, services and brands of the company.
* Key competitors - A list of key competitors to the company.
* Key employees - A list of the key executives of the company.
* Executive biographies - A brief summary of the executives' employment history.
* Key operational heads - A list of personnel heading key departments/functions.
* Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
* Key manufacturing facilities - A list of key manufacturing facilities of the company.
* Detailed financial ratios for the past five years - The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
* Interim ratios for the last five interim periods - The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.

* The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.

* The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.

* Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.

* Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.

* Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

About GlobalData

GlobalData is a leading provider of global business intelligence including market, competitor, product and customer information. It provides in-depth research, analysis, data and forecasts through a range of interactive online databases, reports and management briefings. GlobalData has a large team of experienced research and analysis, consulting, and marketing experts. It has a global presence, including key offices in the US, Europe and Asia. The group has over 50 years of experience of delivering market intelligence data and analysis and a highly experienced senior management team. View more research from GlobalData at www.fastmr.com/catalog/publishers.aspx?pubid=1015

About Fast Market Research

Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available.

For more information about these or related research reports, please visit our website at www.fastmr.com or call us at 1.800.844.8156.


Author:
Bill Thompson
e-mail
Web: www.fastmr.com
Phone: 18008448156

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News
www.newsenvoy.com

 


Terms & Conditions | Privacy | About us | Contact PR-inside.com | BidVertiser